5A3-22428-06127
4 vaccinations
9 coded responses
35 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 300 / GA
- Registered
- 2021-04-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-30
Registered in v-safe
-
2021-04-30
Dose 2 — Pfizer-BioNTech
- 2021-04-30
-
2021-05-01
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Extreme dizziness at 11AMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-05-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-05-04
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-05-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-05-07
-
2021-05-14
Survey response — day 14, dose 2MedDRA: Rash, Vision blurred — Feeling: GoodFree text: Blurred vision and rash around eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-21
- 2021-05-28
- 2021-06-04
-
2021-06-11
Survey response — day 42, dose 2MedDRA: Pre-existing disease — Feeling: FairFree text: Chronic ringing in the earsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-30
- 2021-10-29
-
2022-01-06
Dose 3 — Pfizer-BioNTech
-
2022-01-07
Survey response — days 1–6 daily, dose 3MedDRA: Vision blurred — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Blurred visionMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Survey response — days 1–6 daily, dose 3MedDRA: Balance disorder — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesFree text: Off-balanceMedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2022-01-11
Survey response — days 1–6 daily, dose 3MedDRA: Balance disorder, Vision blurred — Feeling: Good · Site: Pain · HeadacheFree text: Blurred vision, off-balanceMedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-14
Health check-in — day 7, dose 3Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-20
Survey response — day 14, dose 3MedDRA: Postmenopausal haemorrhage — Feeling: GoodFree text: I have had postmenopausal bleeding for about three weeks. I was not aware that that was a symptom of the vaccines; my cycles ended over ten years ago never having any spotting.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Survey response — day 21, dose 3MedDRA: Thrombosis, Vaginal haemorrhage — Feeling: GoodFree text: When I reported to you that I was having vaginal bleeding, I experienced the bleeding and clotting for three months, not for three weeks. After submitting my information, I could not change the weeks to months.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-04
- 2022-02-10
- 2022-02-17
- 2022-04-07
-
2022-07-07
Survey response — 6 months, dose 3MedDRA: Cough, Fatigue — Feeling: GoodFree text: Slight cough, tiredMedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Dose 4 — Pfizer-BioNTech
- 2022-12-06
- 2022-12-07
- 2022-12-08
- 2022-12-09
- 2022-12-16
- 2022-12-23
- 2023-06-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech | |
| 3 | 2022-01-06 | Pfizer-BioNTech | No |
| 4 | 2022-12-02 | Pfizer-BioNTech | No |
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Extreme dizziness at 11A
Release 8 — day 14, dose 2
Symptoms: Blurred vision and rash around eyes
Release 9 — day 42, dose 2
Symptoms: Chronic ringing in the ears
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Blurred vision
Systemic reaction (other): Off-balance
Systemic reaction (other): Blurred vision, off-balance
Release 10 — day 14, dose 3
Symptoms: I have had postmenopausal bleeding for about three weeks. I was not aware that that was a symptom of the vaccines; my cycles ended over ten years ago never having any spotting.
Release 11 — day 21, dose 3
Symptoms: When I reported to you that I was having vaginal bleeding, I experienced the bleeding and clotting for three months, not for three weeks. After submitting my information, I could not change the weeks to months.
Release 12 — 6 months, dose 3
Symptoms: Slight cough, tired
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Postmenopausal haemorrhage | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Thrombosis | · | · | ✓ |
| SD | Vaginal haemorrhage | · | · | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
| SRO | Balance disorder | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Vision blurred | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release